BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Healthtrust
Julphar
Federal Trade Commission
Harvard Business School
Merck
Moodys
Argus Health
Colorcon

Generated: January 21, 2018

DrugPatentWatch Database Preview

MEDROXYPROGESTERONE ACETATE Drug Profile

« Back to Dashboard

When do Medroxyprogesterone Acetate patents expire, and what generic alternatives are available?

Medroxyprogesterone Acetate is a drug marketed by Sandoz Inc, Teva Pharms Usa, Barr, Duramed Pharms Barr, and Usl Pharma. and is included in six NDAs.

The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Drug patent expirations by year for MEDROXYPROGESTERONE ACETATE
Pharmacology for MEDROXYPROGESTERONE ACETATE
Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for MEDROXYPROGESTERONE ACETATE

US Patents and Regulatory Information for MEDROXYPROGESTERONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 078711-001 May 20, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040311-001 Dec 1, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159-001 Aug 9, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040311-002 Dec 1, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 076552-001 Oct 27, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 076553-001 Jul 28, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159-003 Aug 9, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159-002 Aug 9, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 088484-001 Jul 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040311-003 Dec 1, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Novartis
QuintilesIMS
Farmers Insurance
Chinese Patent Office
Johnson and Johnson
Argus Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot